Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE
Journal of Allergy and Clinical Immunology: Global · 2024-11 · 3 (4) · 100327
DOI: 10.1016/j.jacig.2024.100327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2024-11. Verfasst von Amber U Luong und 8 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School of the University of Texas Health Science Center, Houston, Tex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK.
Abstract (Originalsprache)
Background
In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal polyps.
Objective
Our aim was to investigate relationships between NPS and (1) peak nasal inspiratory flow (PNIF) and (2) patient-reported outcomes.
Methods
In this post hoc analysis, patients randomized 1:1 received mepolizumab, 100 mg, or placebo subcutaneously every 4 weeks (plus standard of care). Changes from baseline in PNIF (week 52), visual analog scale scores (overall symptoms, nasal obstruction, and loss of smell [weeks 49-52]), and total 22-Item Sino-Nasal Outcome Test score (week 52) were assessed in patients with or without improvements in NPS (improvement of ≥1 point) or without (improvement of
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- McGovern Medical School of the University of Texas Health Science Center, Houston, Tex.
- Emory University School of Medicine, Atlanta, Ga.
- Center for Rhinology and Allergology, Wiesbaden, Germany.
- Macquarie Medical School, Sydney, Australia.
- US Medical Affairs - Respiratory, GSK, Durham, NC.
- Clinical Sciences, Respiratory, GSK, Durham, NC.
Förderung
- GSK
Zitieren
APA
Luong, A. U., Levy, J. M., Klimek, L., Harvey, R. J., Silver, J., Smith, S. G., Fuller, A., Chan, R., & Hellings, P. W. (2024). Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE. Journal of Allergy and Clinical Immunology: Global, 3(4), 100327. https://doi.org/10.1016/j.jacig.2024.100327
Vancouver
Luong AU, Levy JM, Klimek L, Harvey RJ, Silver J, Smith SG, et al. Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE. Journal of Allergy and Clinical Immunology: Global. 2024;3(4):100327. doi:10.1016/j.jacig.2024.100327
BibTeX
@article{Luong2024,
author = {Luong, Amber U and Levy, Joshua M and Klimek, Ludger and Harvey, Richard J and Silver, Jared and Smith, Steven G and Fuller, Abby and Chan, Robert and Hellings, Peter W},
title = {Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE},
journal = {Journal of Allergy and Clinical Immunology: Global},
year = {2024},
volume = {3},
number = {4},
pages = {100327},
doi = {10.1016/j.jacig.2024.100327}
}
EUVIMED